Lunit AI Maps the Tumor-Immune Landscape to Predict Immunotherapy Response and Discover New Antibody Targets at SITC 2025
recent articles
SPOKANE, Wash., June 18, 2025 /PRNewswire/ -- Gestalt, a leading provider of AI-powered digital pathology solutions, today announced the addition of Dr. Renuka Kulkarni, MD, as Chief Medical Officer (CMO). A physician scientist with over 20...
Lumea's Viewer+™ digital pathology platform was selected by GI Alliance, a top US GI network, to enhance diagnostic efficiency and workflow nationwide. LEHI, UT, UNITED STATES, June 17, 2025 /EINPresswire.com/ -- GI Alliance, the leading...
Roche: Information platform empowers the public with knowledge on latest cancer treatment technologies According to data from the Hong Kong Cancer Registry of the Hospital Authority, the overall five-year survival rate for cancer patients has...
Results from Phase IIb PADOVA and longer term follow-up data suggest clinical benefit on top of symptomatic treatment in early-stage Parkinson’s disease Prasinezumab is a potential first-in-class anti-alpha-synuclein antibody,...
Artera: Clinicians and patients throughout New York State can now access personalized, actionable insights to inform prostate cancer treatment decisions SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of multimodal...
Proscia: Survey of 360 senior professionals finds modernization is key to overcoming longstanding industry challenges PHILADELPHIA — June 11, 2025 — Diagnostic laboratory leaders view digital pathology and artificial intelligence (AI)...
